Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 3/20 | 0.35 |
| ▸ | DPP4 | P27487 | 3/20 | 0.35 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.31 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.31 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.31 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.31 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.31 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.31 |
| ▸ | PTGDR | Q13258 | 1/20 | 0.30 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.30 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.30 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.30 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.30 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.30 |
| ▸ | MMP1 | P03956 | 1/20 | 0.30 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | MMP3 | P08254 | 1/20 | 0.30 |
| ▸ | MMP9 | P14780 | 1/20 | 0.30 |
| ▸ | MMP8 | P22894 | 1/20 | 0.30 |
| ▸ | MMP12 | P39900 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13521562 | 0.98 | ANPEP (0.36) | ANPEPDPP4 | |
| SCHEMBL12414742 | 0.93 | KDM4E (0.33) | ANPEPDPP4ADRB2ADRB1ADRB3 | |
| SCHEMBL12414733 | 0.92 | ANPEP (0.38) | ANPEPDPP4ADRB2ADRB1ADRB3 | |
| SCHEMBL12506421 | 0.91 | KDM4E (0.34) | ANPEPDPP4ADRB2ADRB1ADRB3 | |
| SCHEMBL12414728 | 0.86 | MCL1 (0.33) | ANPEPDPP4 | |
| SCHEMBL12414739 | 0.86 | KDM4E (0.33) | ANPEPDPP4ADRB2ADRB1ADRB3 | |
| SCHEMBL12414744 | 0.85 | ANPEP (0.36) | ANPEPDPP4 | |
| SCHEMBL15508935 | 0.84 | NR1H2 (0.34) | ANPEPDPP4PTGDRNR1H2MMP1 | |
| SCHEMBL13532263 | 0.84 | ANPEP (0.33) | ANPEPDPP4 | |
| SCHEMBL12414732 | 0.83 | ANPEP (0.39) | ANPEPDPP4NR1H2NR1H3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8921558-B2 | Azide substituted naphthylene or rylene imide derivatives and their use as reagents in click-reactions | BASF SE (DE) | 2014-12-30 | — | — | US | disclosed |
| US-8802852-B2 | Azide substituted naphthylene or rylene imide derivatives and their use as reagents in click-reactions | BASF SE (DE) | 2014-08-12 | — | — | US | disclosed |
| US-20140080220-A1 | Azide Substituted Naphthylene or Rylene Imide Derivatives and their Use as Reagents in Click-Reactions | BASF SE (DE) | 2014-03-20 | — | — | US | disclosed |
| US-20140073059-A1 | Azide Substituted Naphthylene or Rylene Imide Derivatives and their Use as Reagents in Click-Reactions | BASF SE (DE) | 2014-03-13 | — | — | US | disclosed |
| US-20110165691-A1 | AZIDE SUBSTITUTED NAPHTHYLENE OR RYLENE IMIDE DERIVATIVES AND THEIR USE AS REAGENTS IN CLICK-REACTIONS | BASF SE (DE) | 2011-07-07 | — | — | US | disclosed |
| US-20110165691-A1 | AZIDE SUBSTITUTED NAPHTHYLENE OR RYLENE IMIDE DERIVATIVES AND THEIR USE AS REAGENTS IN CLICK-REACTIONS | BASF SE (DE) | 2011-07-07 | — | — | US | disclosed |
| WO-2010010198-A2 | NEW AZIDE SUBSTITUTED NAPHTHYLENE OR RYLENE IMIDE DERIVATIVES AND THEIR USE AS REAGENTS IN CLICK-REACTIONS | BASF SE (DE) | 2010-01-28 | — | — | WO | disclosed |
| US-20100022021-A1 | NEW AZIDE SUBSTITUTED NAPHTHYLENE OR RYLENE IMIDE DERIVATIVES AND THEIR USE AS REAGENTS IN CLICK-REACTIONS | BASF SE (DE) | 2010-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140080220-A1 | Azide Substituted Naphthylene or Rylene Imide Derivatives and their Use as Reagents in Click-Reactions | NANS, NANP, GNE | ANPEP 119/4885DPP4 1737/4885PSEN1 4833/4885 |
| US-20100022021-A1 | NEW AZIDE SUBSTITUTED NAPHTHYLENE OR RYLENE IMIDE DERIVATIVES AND THEIR USE AS REAGENTS IN CLICK-REACTIONS | NANS, NANP, GNE | ANPEP 106/4885DPP4 1726/4885PSEN1 4826/4885 |
| US-20110165691-A1 | AZIDE SUBSTITUTED NAPHTHYLENE OR RYLENE IMIDE DERIVATIVES AND THEIR USE AS REAGENTS IN CLICK-REACTIONS | NANS, NANP, GNE | ANPEP 119/4885DPP4 1737/4885PSEN1 4833/4885 |
| US-20140073059-A1 | Azide Substituted Naphthylene or Rylene Imide Derivatives and their Use as Reagents in Click-Reactions | NANS, NANP, GNE | ANPEP 119/4885DPP4 1737/4885PSEN1 4833/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.